These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20831677)

  • 1. Investigation of the prediction accuracy of vancomycin concentrations determined by patient-specific parameters as estimated by Bayesian analysis.
    Hiraki Y; Onga T; Mizoguchi A; Tsuji Y
    J Clin Pharm Ther; 2010 Oct; 35(5):527-32. PubMed ID: 20831677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
    Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
    J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Persistent bacteremia due to methicillin-resistant Staphylococcus aureus. A result of inadequate treatment].
    Parra-Ruiz J; Tomas-Jiménez C; Muñoz-Medina L; Hernández-Quero J
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):372-3. PubMed ID: 19339080
    [No Abstract]   [Full Text] [Related]  

  • 6. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
    Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
    Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
    Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
    Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is peak concentration needed in therapeutic drug monitoring of vancomycin? A pharmacokinetic-pharmacodynamic analysis in patients with methicillin-resistant staphylococcus aureus pneumonia.
    Suzuki Y; Kawasaki K; Sato Y; Tokimatsu I; Itoh H; Hiramatsu K; Takeyama M; Kadota J
    Chemotherapy; 2012; 58(4):308-12. PubMed ID: 23147106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin dosing and monitoring.
    Med Lett Drugs Ther; 2009 Apr; 51(1309):25. PubMed ID: 19343006
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of Vancomycin Dose Individualization Strategy by Bayesian Prediction in Patients Receiving Continuous Renal Replacement Therapy.
    Oda K; Jono H; Kamohara H; Nishi K; Tanoue N; Saito H
    Pharm Res; 2020 May; 37(6):108. PubMed ID: 32468340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New target concentrations for vancomycin in Hong Kong.
    You JH; Chow SS; Lui JW; Ip M
    Int J Antimicrob Agents; 2011 Jan; 37(1):83-4. PubMed ID: 21074378
    [No Abstract]   [Full Text] [Related]  

  • 12. Population pharmacokinetics of vancomycin in Japanese adult patients.
    Yasuhara M; Iga T; Zenda H; Okumura K; Oguma T; Yano Y; Hori R
    Ther Drug Monit; 1998 Apr; 20(2):139-48. PubMed ID: 9558127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of vancomycin in adult cancer patients.
    Al-Kofide H; Zaghloul I; Al-Naim L
    J Oncol Pharm Pract; 2010 Dec; 16(4):245-50. PubMed ID: 20015925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin therapeutics and monitoring: a contemporary approach.
    Avent ML; Vaska VL; Rogers BA; Cheng AC; van Hal SJ; Holmes NE; Howden BP; Paterson DL
    Intern Med J; 2013 Feb; 43(2):110-9. PubMed ID: 23185970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
    Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
    J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
    Bhavnani SM; Prakhya A; Hammel JP; Ambrose PG
    Clin Infect Dis; 2009 Sep; 49(5):691-8. PubMed ID: 19635023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation of pharmacokinetic parameters with serum vancomycin concentration in elderly patients with malignancies].
    Sadoh S; Tsuji Y; Tsukamoto K
    Yakugaku Zasshi; 2010 Jan; 130(1):69-73. PubMed ID: 20046068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin pharmacokinetics in patients with severe burn injuries.
    Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
    Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.